Todd Hulgan, M.D., M.P.H.

Director PC-SWG, Associate Professor of Medicine, Division of Infectious Diseases
Vanderbilt University School of Medicine

Todd Hulgan, MD, MPH serves as Director of the PC-SWG. He is a recognized leader in mitochondrial pharmacogenomics, having led the first studies of mitochondrial haplogroups and risk of ART-associated adverse outcomes in HIV-infected individuals.  His recent work has explored the role of mitochondrial DNA variation in inter-individual and population differences in CD4 recovery.  For >8 years, Dr. Hulgan has led a highly collaborative and successful Human Genomics and HIV Working Group that has met every 1-2 weeks in the VU Center for Human Genetics Research. His commitment and success in collaborative team research, and prior work with the VU DBMI around implementation of computerized decision support makes him ideally suited to lead this SWG.